| Dataset | DeepCoverMOA Drug Mechanisms of Action |
| Category | proteomics |
| Type | drug perturbation |
| Description | A tripeptide consisting of an Ile-Ile-Thr-NH2 sequence N-substituted on the threonamide amidic nitrogen with a (2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl group and with acetyl and methyl groups on the nitrogen of the isoleucine residue distal to the threonamide; a naturally occurring selective proteasome inhibitor with anti-inflammatory activity. (Chemical Entities of Biological Interest Ontology, CHEBI_42265) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/11226684 |
| Similar Terms | |
| Downloads & Tools |
199 proteins with high or low expression in Epoxomicin relative to other proteins from the DeepCoverMOA Drug Mechanisms of Action dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| DEDD2 | death effector domain containing 2 | 6.89 |
| ZFAND2A | zinc finger, AN1-type domain 2A | 6.44 |
| OSGIN1 | oxidative stress induced growth inhibitor 1 | 6.43 |
| PPP1R15A | protein phosphatase 1, regulatory subunit 15A | 6.07 |
| PLK2 | polo-like kinase 2 | 5.32 |
| IER5 | immediate early response 5 | 5.31 |
| XBP1 | X-box binding protein 1 | 5.07 |
| HKDC1 | hexokinase domain containing 1 | 5.05 |
| STC2 | stanniocalcin 2 | 4.77 |
| AZIN1 | antizyme inhibitor 1 | 4.75 |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 4.74 |
| NFE2L2 | nuclear factor, erythroid 2-like 2 | 4.74 |
| TRIB3 | tribbles pseudokinase 3 | 4.67 |
| MIDN | midnolin | 4.66 |
| RND3 | Rho family GTPase 3 | 4.55 |
| CHAC1 | ChaC glutathione-specific gamma-glutamylcyclotransferase 1 | 4.52 |
| ATF3 | activating transcription factor 3 | 4.5 |
| DDIT4 | DNA-damage-inducible transcript 4 | 4.41 |
| IER2 | immediate early response 2 | 4.36 |
| SESN2 | sestrin 2 | 4.34 |
| JUN | jun proto-oncogene | 4.31 |
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4.15 |
| PIM1 | Pim-1 proto-oncogene, serine/threonine kinase | 4.15 |
| NFE2L1 | nuclear factor, erythroid 2-like 1 | 4.01 |
| MYC | v-myc avian myelocytomatosis viral oncogene homolog | 3.88 |
| SYTL3 | synaptotagmin-like 3 | 3.78 |
| ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 | 3.74 |
| CREB3L2 | cAMP responsive element binding protein 3-like 2 | 3.74 |
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 3.71 |
| LRRC58 | leucine rich repeat containing 58 | 3.54 |
| AEN | apoptosis enhancing nuclease | 3.52 |
| CDC6 | cell division cycle 6 | 3.5 |
| PIM3 | Pim-3 proto-oncogene, serine/threonine kinase | 3.49 |
| GEM | GTP binding protein overexpressed in skeletal muscle | 3.48 |
| HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 3.43 |
| BHLHE40 | basic helix-loop-helix family, member e40 | 3.4 |
| CLU | clusterin | 3.38 |
| MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase | 3.37 |
| MARCHF7 | membrane associated ring-CH-type finger 7 | 3.34 |
| F10 | coagulation factor X | 3.32 |
| DUSP5 | dual specificity phosphatase 5 | 3.3 |
| MAGEA6 | melanoma antigen family A6 | 3.28 |
| IP6K2 | inositol hexakisphosphate kinase 2 | 3.28 |
| TRIB1 | tribbles pseudokinase 1 | 3.28 |
| AKR1C2 | aldo-keto reductase family 1, member C2 | 3.25 |
| CCND3 | cyclin D3 | 3.24 |
| TNFRSF10D | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain | 3.23 |
| LAMB3 | laminin, beta 3 | 3.22 |
| IFRD1 | interferon-related developmental regulator 1 | 3.2 |
| ABHD4 | abhydrolase domain containing 4 | 3.17 |
| DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 3.13 |
| AKIRIN2 | akirin 2 | 3.1 |
| MCL1 | myeloid cell leukemia 1 | 3.06 |
| BRF2 | BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit | 3.05 |
| MORC4 | MORC family CW-type zinc finger 4 | 3.03 |
| BAHCC1 | BAH domain and coiled-coil containing 1 | 3.03 |
| SNAI1 | snail family zinc finger 1 | 3.01 |
| HMOX1 | heme oxygenase 1 | 2.98 |
| HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | 2.96 |
| DUSP6 | dual specificity phosphatase 6 | 2.96 |
| ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 | 2.94 |
| KLHL21 | kelch-like family member 21 | 2.91 |
| MORF4L2 | mortality factor 4 like 2 | 2.89 |
| AMOTL2 | angiomotin like 2 | 2.86 |
| C16ORF72 | chromosome 16 open reading frame 72 | 2.82 |
| MAGEA12 | melanoma antigen family A12 | 2.82 |
| HIPK1 | homeodomain interacting protein kinase 1 | 2.8 |
| ZFAND5 | zinc finger, AN1-type domain 5 | 2.79 |
| TNFAIP1 | tumor necrosis factor, alpha-induced protein 1 (endothelial) | 2.76 |
| CDT1 | chromatin licensing and DNA replication factor 1 | 2.72 |
| TENT5A | terminal nucleotidyltransferase 5A | 2.71 |
| ELL2 | elongation factor, RNA polymerase II, 2 | 2.66 |
| ENC1 | ectodermal-neural cortex 1 (with BTB domain) | 2.66 |
| PCGF1 | polycomb group ring finger 1 | 2.65 |
| ABHD2 | abhydrolase domain containing 2 | 2.64 |
| STK17A | serine/threonine kinase 17a | 2.63 |
| IFFO2 | intermediate filament family orphan 2 | 2.62 |
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 2.62 |
| ODC1 | ornithine decarboxylase 1 | 2.57 |
| ZNF451 | zinc finger protein 451 | 2.57 |
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 2.55 |
| TUFT1 | tuftelin 1 | 2.52 |
| BLZF1 | basic leucine zipper nuclear factor 1 | 2.52 |
| CHRNA5 | cholinergic receptor, nicotinic, alpha 5 (neuronal) | 2.51 |
| BAG3 | BCL2-associated athanogene 3 | 2.5 |
| PTOV1 | prostate tumor overexpressed 1 | 2.49 |
| ADM | adrenomedullin | 2.49 |
| CCND1 | cyclin D1 | 2.48 |
| CPA4 | carboxypeptidase A4 | 2.48 |
| HIPK3 | homeodomain interacting protein kinase 3 | 2.47 |
| DAPK2 | death-associated protein kinase 2 | 2.47 |
| TNKS | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase | 2.46 |
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 2.46 |
| RNF187 | ring finger protein 187 | 2.46 |
| LAMC2 | laminin, gamma 2 | 2.45 |
| OSER1 | oxidative stress responsive serine-rich 1 | 2.42 |
| CLK1 | CDC-like kinase 1 | 2.38 |
| TRIM35 | tripartite motif containing 35 | 2.37 |
| SREBF1 | sterol regulatory element binding transcription factor 1 | 2.37 |
| E2F7 | E2F transcription factor 7 | 2.37 |
| Symbol | Name | Standardized Value |
|---|---|---|
| MT2A | metallothionein 2A | -6.14 |
| SDC1 | syndecan 1 | -3.73 |
| MDK | midkine (neurite growth-promoting factor 2) | -3.4 |
| SDC4 | syndecan 4 | -3.1 |
| MT1E | metallothionein 1E | -2.53 |
| PROCR | protein C receptor, endothelial | -2.34 |
| TIMM8B | translocase of inner mitochondrial membrane 8 homolog B (yeast) | -2.17 |
| GLG1 | golgi glycoprotein 1 | -2.08 |
| HMGN4 | high mobility group nucleosomal binding domain 4 | -2.06 |
| RTN4R | reticulon 4 receptor | -2.04 |
| MT1F | metallothionein 1F | -2.02 |
| FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | -1.96 |
| ZNF428 | zinc finger protein 428 | -1.95 |
| ZNF22 | zinc finger protein 22 | -1.94 |
| DNAJC15 | DnaJ (Hsp40) homolog, subfamily C, member 15 | -1.92 |
| PTMA | prothymosin, alpha | -1.91 |
| DGCR2 | DiGeorge syndrome critical region gene 2 | -1.89 |
| MIEN1 | migration and invasion enhancer 1 | -1.89 |
| ADGRL1 | adhesion G protein-coupled receptor L1 | -1.86 |
| ERVMER34-1 | endogenous retrovirus group MER34, member 1 | -1.85 |
| ATXN7L3B | ataxin 7-like 3B | -1.78 |
| ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | -1.78 |
| MT1X | metallothionein 1X | -1.74 |
| DERPC | DERPC proline and glycine rich nuclear protein | -1.69 |
| DNAH5 | dynein, axonemal, heavy chain 5 | -1.69 |
| NLRC3 | NLR family, CARD domain containing 3 | -1.66 |
| SIRT3 | sirtuin 3 | -1.6 |
| MT1L | metallothionein 1L (gene/pseudogene) | -1.6 |
| DGKQ | diacylglycerol kinase, theta 110kDa | -1.6 |
| ASIC1 | acid sensing (proton gated) ion channel 1 | -1.58 |
| NCBP2AS2 | NCBP2 antisense 2 (head to head) | -1.56 |
| AOC1 | amine oxidase, copper containing 1 | -1.56 |
| CHST14 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 | -1.55 |
| THAP3 | THAP domain containing, apoptosis associated protein 3 | -1.53 |
| FDX1 | ferredoxin 1 | -1.53 |
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | -1.52 |
| POFUT2 | protein O-fucosyltransferase 2 | -1.52 |
| FGD1 | FYVE, RhoGEF and PH domain containing 1 | -1.52 |
| FAM3C | family with sequence similarity 3, member C | -1.49 |
| COA5 | cytochrome c oxidase assembly factor 5 | -1.46 |
| CHCHD2P9 | coiled-coil-helix-coiled-coil-helix domain containing 2 pseudogene 9 | -1.46 |
| GALNT11 | polypeptide N-acetylgalactosaminyltransferase 11 | -1.46 |
| ZNF185 | zinc finger protein 185 (LIM domain) | -1.44 |
| MTERF3 | mitochondrial transcription termination factor 3 | -1.44 |
| ONECUT3 | one cut homeobox 3 | -1.44 |
| SORT1 | sortilin 1 | -1.42 |
| ISYNA1 | inositol-3-phosphate synthase 1 | -1.42 |
| MRPL34 | mitochondrial ribosomal protein L34 | -1.42 |
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | -1.4 |
| SLC25A28 | solute carrier family 25 (mitochondrial iron transporter), member 28 | -1.39 |
| PSMG4 | proteasome (prosome, macropain) assembly chaperone 4 | -1.38 |
| RAB37 | RAB37, member RAS oncogene family | -1.38 |
| ADAT2 | adenosine deaminase, tRNA-specific 2 | -1.38 |
| DENND2D | DENN/MADD domain containing 2D | -1.38 |
| SMIM12 | small integral membrane protein 12 | -1.34 |
| SDHAF4 | succinate dehydrogenase complex assembly factor 4 | -1.34 |
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | -1.34 |
| SDHAF3 | succinate dehydrogenase complex assembly factor 3 | -1.33 |
| AKAP11 | A kinase (PRKA) anchor protein 11 | -1.32 |
| PNKD | paroxysmal nonkinesigenic dyskinesia | -1.31 |
| HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | -1.31 |
| RWDD1 | RWD domain containing 1 | -1.3 |
| PCBD2 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 | -1.3 |
| ADAM22 | ADAM metallopeptidase domain 22 | -1.3 |
| TUSC2 | tumor suppressor candidate 2 | -1.28 |
| TMEM231 | transmembrane protein 231 | -1.28 |
| MAN1B1 | mannosidase, alpha, class 1B, member 1 | -1.28 |
| ABHD18 | abhydrolase domain containing 18 | -1.28 |
| NEU1 | sialidase 1 (lysosomal sialidase) | -1.27 |
| FXN | frataxin | -1.27 |
| HMGN2 | high mobility group nucleosomal binding domain 2 | -1.27 |
| GPC1 | glypican 1 | -1.27 |
| SORL1 | sortilin-related receptor, L(DLR class) A repeats containing | -1.26 |
| PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | -1.25 |
| H1-0 | H1.0 linker histone | -1.24 |
| RCN2 | reticulocalbin 2, EF-hand calcium binding domain | -1.24 |
| CRIP1 | cysteine-rich protein 1 (intestinal) | -1.24 |
| ANTKMT | adenine nucleotide translocase lysine methyltransferase | -1.24 |
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | -1.23 |
| ZNF175 | zinc finger protein 175 | -1.21 |
| RTL8C | retrotransposon Gag like 8C | -1.21 |
| MAN1A1 | mannosidase, alpha, class 1A, member 1 | -1.21 |
| CHST12 | carbohydrate (chondroitin 4) sulfotransferase 12 | -1.21 |
| TMEM165 | transmembrane protein 165 | -1.2 |
| NUTF2 | nuclear transport factor 2 | -1.2 |
| SF1 | splicing factor 1 | -1.2 |
| CR2 | complement component (3d/Epstein Barr virus) receptor 2 | -1.2 |
| HMGN1 | high mobility group nucleosome binding domain 1 | -1.19 |
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | -1.19 |
| CACHD1 | cache domain containing 1 | -1.19 |
| GPC4 | glypican 4 | -1.18 |
| C15ORF61 | chromosome 15 open reading frame 61 | -1.18 |
| ZNRF1 | zinc and ring finger 1, E3 ubiquitin protein ligase | -1.18 |
| FAM162A | family with sequence similarity 162, member A | -1.18 |
| TCOF1 | Treacher Collins-Franceschetti syndrome 1 | -1.18 |
| CTSB | cathepsin B | -1.17 |
| MSRB2 | methionine sulfoxide reductase B2 | -1.17 |
| CLNS1A | chloride channel, nucleotide-sensitive, 1A | -1.16 |
| ARL2BP | ADP-ribosylation factor-like 2 binding protein | -1.16 |